Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
(NQ:
)
N/A
UNCHANGED
Last Price
/ Updated:
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
-
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
-
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
N/A
Dividend Yield
N/A
Top News
More News
APP Pharmaceuticals to Present at Credit Suisse Healthcare Conference
November 12, 2007
from
Business Wire News Releases
Abraxis BioScience Announces the Closing Date for the Separation of Its Proprietary Business from Its Hospital-Based Business
November 08, 2007
Close Scheduled to Occur on November 13, 2007 APP Pharmaceuticals, the Hospital-Based Business, Reports Last Twelve Month Revenue of $653 Million and Expects Adjusted EBITDA to be between $258 and $263...
Read More
from
Business Wire News Releases
More News
Read More
Abraxis BioScience Reports an Increase in Third Quarter Revenue of 19 Percent to $241 Million versus $203 Million in Prior Year Period
November 08, 2007
from
Business Wire News Releases
Abraxis BioScience Announces Record and Distribution Date in Connection with the Separation of Its Businesses
November 07, 2007
from
Business Wire News Releases
Cenomed BioSciences Co-Awarded Chemical Defense Grant by JSTO-CBD/DTRA to Evaluate the Use of Novel Compounds to Enhance the Effectiveness of Currently Used Nerve Agent Treatments
November 05, 2007
from
Business Wire News Releases
Abraxis BioScience Announces Date for Third Quarter Financial Results and Investor Conference Call
October 25, 2007
from
Business Wire News Releases
Abraxis BioScience Receives a Positive Opinion in Europe from the CHMP for the Approval of ABRAXANE for the Treatment of Metastatic Breast Cancer
October 18, 2007
from
Business Wire News Releases
Abraxis BioScience and Biocon Limited Announce Approval of ABRAXANE in India for the Treatment of Breast Cancer
October 18, 2007
from
Business Wire News Releases
APP Receives FDA Approval for Epirubicin HCl Injection
October 17, 2007
from
Business Wire News Releases
Abraxis Pharmaceutical Products (ABBI) Receives Two FDA Approvals
October 17, 2007
from
StreetInsider.com News Articles
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here